Cargando…

Real-Life Report on Chemoembolization Using DEBIRI for Liver Metastases from Colorectal Cancer

Background. Transarterial chemoembolization (TACE) has been investigated in patients with liver metastases from colorectal cancer (LMCRC). Limited experience and available data suggest that TACE can achieve disease stabilization or improvement, even in heavily pretreated patients. Methods. Patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stutz, M., Mamo, A., Valenti, D., Hausvater, A., Cabrera, T., Metrakos, P., Chaudhury, P., Steacy, G., Garoufalis, E., Kavan, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357048/ https://www.ncbi.nlm.nih.gov/pubmed/25815009 http://dx.doi.org/10.1155/2015/715102

Ejemplares similares

Updates of colorectal cancer liver metastases therapy: review on DEBIRI
por: Fiorentini, Giammaria, et al.
Publicado: (2020)

Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug-Eluting Beads, Irinotecan (DEBIRI): Multi-Institutional Registry
por: Martin, Robert C. G., et al.
Publicado: (2009)

The Role of Conventional TACE (cTACE) and DEBIRI-TACE in Colorectal Cancer Liver Metastases
por: Vogl, Thomas J., et al.
Publicado: (2022)

First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI)
por: EICHLER, K., et al.
Publicado: (2012)

Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study
por: Pernot, Simon, et al.
Publicado: (2020)

Small Particle DEBIRI TACE as Salvage Therapy in Patients with Liver Dominant Colorectal Cancer Metastasis: Retrospective Analysis of Safety and Outcomes
por: Voizard, Nicolas, et al.
Publicado: (2022)

Case report and literature review: PET/CT in the evaluation of response to treatment of liver metastasis from colorectal cancer with DEBIRI-TACE
por: Jin, Lan, et al.
Publicado: (2023)

Transarterial chemoembolization alone or followed by bevacizumab for treatment of colorectal liver metastases
por: Fiorentini, Giammaria, et al.
Publicado: (2021)

Transcatheter Arterial Chemoembolization Is a Feasible Palliative Locoregional Therapy for Breast Cancer Liver Metastases
por: Cho, Sung W., et al.
Publicado: (2010)

A Retrospective Study on the Role of Metformin in Colorectal Cancer Liver Metastases
por: Rada, Miran, et al.
Publicado: (2023)

Evaluation of MR elastography as a response parameter for transarterial chemoembolization of colorectal liver metastases
por: Vogl, Thomas J., et al.
Publicado: (2020)

The molecular mechanisms underlying neutrophil infiltration in vessel co-opting colorectal cancer liver metastases
por: Rada, Miran, et al.
Publicado: (2022)

Initial Experiences of Simultaneous Laparoscopic Resection of Colorectal Cancer and Liver Metastases
por: Hoekstra, L. T., et al.
Publicado: (2012)

Safe liver resection following chemotherapy for colorectal metastases is a matter of timing
por: Welsh, F K S, et al.
Publicado: (2007)

Targeting Liver Metastases to Potentiate Immunotherapy in MS-Stable Colorectal Cancer—A Review of the Literature
por: Zlotnik, Oran, et al.
Publicado: (2023)

Transvenous Pulmonary Chemoembolization and Optional Microwave Ablation for Colorectal Lung Metastases
por: Vogl, Thomas J., et al.
Publicado: (2023)

Effect of portal vein embolisation on the growth rate of colorectal liver metastases
por: Pamecha, V, et al.
Publicado: (2009)

FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer
por: Bertolini, F, et al.
Publicado: (2011)

C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases
por: Wong, V K H, et al.
Publicado: (2007)

Histologic features and genomic alterations of primary colorectal adenocarcinoma predict growth patterns of liver metastasis
por: Wu, Jing-Bo, et al.
Publicado: (2019)

Therapeutic effect and tolerability of gelatin sponge particle-mediated chemoembolization for colorectal liver metastases: a retrospective study
por: Li, Chuang, et al.
Publicado: (2013)

Conversion to resectability using transcatheter arterial chemoembolization alternating with mFOLFOX6 in patients with colorectal liver metastases
por: Wang, Shuai, et al.
Publicado: (2019)

Bilateral liver metastases from testicular sex cord-stromal tumour
por: Palmieri, Vincent, et al.
Publicado: (2019)

Long-term outcomes of patients with 10 or more colorectal liver metastases
por: Allard, M A, et al.
Publicado: (2017)

Angiopoietin-1 Upregulates Cancer Cell Motility in Colorectal Cancer Liver Metastases through Actin-Related Protein 2/3
por: Rada, Miran, et al.
Publicado: (2022)

Resection margin influences the outcome of patients with bilobar colorectal liver metastases
por: Di Carlo, Sara, et al.
Publicado: (2016)

Oncological outcomes and predictors of radiofrequency ablation of colorectal cancer liver metastases
por: Wang, Chuan-Zhuo, et al.
Publicado: (2020)

Neoadjuvant FOLFIRI+bevacizumab in patients with resectable liver metastases from colorectal cancer: a phase 2 trial
por: Nasti, G, et al.
Publicado: (2013)

Angiopoietin1 Deficiency in Hepatocytes Affects the Growth of Colorectal Cancer Liver Metastases (CRCLM)
por: Ibrahim, Nisreen S., et al.
Publicado: (2019)

A Reappraisal of Chemotherapy-Induced Liver Injury in Colorectal Liver Metastases before the Era of Antiangiogenics
por: Nguyen-Khac, Eric, et al.
Publicado: (2013)

Efficacy of transcatheter arterial chemoembolization for liver metastases arising from pancreatic cancer
por: Sun, Jun-Hui, et al.
Publicado: (2017)

A proposed new method for assessing the pathological response to chemotherapy in resected colorectal liver metastases
por: Sebagh, M, et al.
Publicado: (2014)

Abnormal expression and processing of the proprotein convertases PC1 and PC2 in human colorectal liver metastases
por: Tzimas, George N, et al.
Publicado: (2005)

Runt related transcription factor-1 plays a central role in vessel co-option of colorectal cancer liver metastases
por: Rada, Miran, et al.
Publicado: (2021)

Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases
por: De Bruyne, S, et al.
Publicado: (2012)

Yttrium-90 Radioembolization for Colorectal Cancer Liver Metastases: A Single Institution Experience
por: Nace, Gary W., et al.
Publicado: (2011)

Impact of homogeneous pathologic response to preoperative chemotherapy in patients with multiple colorectal liver metastases
por: Sabbagh, Charles, et al.
Publicado: (2017)

Prognostic factors and therapeutic effects of different treatment modalities for colorectal cancer liver metastases
por: Ma, Zuo-Hong, et al.
Publicado: (2020)

Correction: Efficacy of transcatheter arterial chemoembolization for liver metastases arising from pancreatic cancer
por: Sun, Jun-Hui, et al.
Publicado: (2018)

Colorectal Liver Metastases
por: Haddad, Ashraf J., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_3j1cv92751bpumnopc0em0hlto